FMS יחס מהיר Fresenius Medical Care Corp

Fresenius Medical Care (FMS) operates a fully integrated kidney therapy cycle, combining equipment manufacturing with a network of centers. The intermediate coverage ratio demonstrates the business's ability to meet obligations without liquidating inventory, where 0.76 determines the current status of the parameter. Stability is ensured by optimized consumables supply chains and the regular upgrading of production lines through the implementation of filter automation.

When assessing the resilience of Fresenius Medical Care (FMS) to market shocks, it is critical to consider the business's ability to immediately settle its debts. A stable stream of payments from dialysis patients creates unique financial inertia and revenue predictability. The history of quick ratio changes reflects the proportion of cash and accounts receivable to short-term liabilities, intentionally excluding inventory. High values of this ratio confirm exceptional solvency and minimize investment risks.